23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.88%
Negative revenue growth while Insurance - Life median is -2.03%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-16.88%
Negative gross profit growth while Insurance - Life median is -1.68%. Seth Klarman would suspect poor product pricing or inefficient production.
18.06%
EBIT growth exceeding 1.5x Insurance - Life median of 1.36%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
18.06%
Operating income growth exceeding 1.5x Insurance - Life median of 2.05%. Joel Greenblatt would see if unique processes drive exceptional profitability.
17.34%
Net income growth exceeding 1.5x Insurance - Life median of 2.73%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
17.36%
EPS growth exceeding 1.5x Insurance - Life median of 2.00%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
17.35%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 2.41%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
55.48%
OCF growth exceeding 1.5x Insurance - Life median of 33.60%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
55.48%
FCF growth exceeding 1.5x Insurance - Life median of 36.45%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
32.57%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 29.52%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
-21.97%
Negative 5Y CAGR while Insurance - Life median is 11.73%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-54.25%
Negative 3Y CAGR while Insurance - Life median is 3.20%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
79.31%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 42.80% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
13.98%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 9.08%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
189.55%
3Y OCF/share growth > 1.5x Insurance - Life median of 40.09%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
52.20%
Net income/share CAGR near Insurance - Life median. Charlie Munger might see typical industry-level profit expansion over 10 years.
737.21%
5Y net income/share CAGR > 1.5x Insurance - Life median of 51.93%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
185.83%
3Y net income/share CAGR > 1.5x Insurance - Life median of 28.92%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
34.02%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 22.33% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
21.42%
5Y equity/share CAGR near Insurance - Life median. Charlie Munger finds it normal mid-term expansion for the industry.
30.14%
3Y equity/share CAGR > 1.5x Insurance - Life median of 19.17%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.88%
AR growth of 2.88% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
3.52%
Asset growth exceeding 1.5x Insurance - Life median of 0.93%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
5.90%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
1.00%
Debt growth of 1.00% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
7.83%
SG&A growth of 7.83% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.